Insights

Growing Market Focus Galatea Bio is actively expanding its presence in precision health and genetic risk assessment, particularly targeting diverse underserved populations across Latin America and the diaspora. This focus offers sales opportunities for partners providing population-specific genomic data services, healthcare analytics, and tailored clinical solutions.

Innovative Testing Platforms The recent launch of StrataRisk Polygenic Risk Score SaaS platform positions Galatea Bio as a leader in disease susceptibility assessment. Sales teams can explore collaborative opportunities in offering integrated genetic analysis tools, clinical reporting solutions, and data curation services to healthcare providers and research institutions.

Strategic Collaborations Partnership with Fabric Genomics to develop genetic disease risk assays highlights Galatea Bio’s openness to collaborative innovations. This creates potential for cross-selling complementary genomic analytics, clinical reporting platforms, and genetic testing services to biotech firms and labs aiming to enhance their precision medicine capabilities.

Significant Funding Growth With recent funding of $25 million and a revenue range of up to $25 million, Galatea Bio demonstrates strong financial backing and growth potential. Sales efforts could target investors and strategic partners interested in expanding genetic diagnostics, risk assessment tools, and biobank data solutions across emerging markets.

Tech-Driven Approach Galatea Bio utilizes advanced cloud-based and web optimization technologies, indicating a focus on scalable, digital health solutions. Sales prospects include offering infrastructure, hosting, and data management services that enhance their platform’s performance and security, appealing to clients seeking reliable, innovative genomic data solutions.

Galatea Bio Inc. Tech Stack

Galatea Bio Inc. uses 8 technology products and services including Cloudflare Web Optimizations, Amazon Simple Email Service, Google Fonts API, and more. Explore Galatea Bio Inc.'s tech stack below.

  • Cloudflare Web Optimizations
    Analytics
  • Amazon Simple Email Service
    Email
  • Google Fonts API
    Font Scripts
  • React Router
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • HSTS
    Security
  • YouTube
    Video Players
  • HTTP/3
    Web & Portal Technology

Media & News

Galatea Bio Inc.'s Email Address Formats

Galatea Bio Inc. uses at least 1 format(s):
Galatea Bio Inc. Email FormatsExamplePercentage
First.Last@galatea.bioJohn.Doe@galatea.bio
47%
First@galatea.bioJohn@galatea.bio
3%
First.Last@galatea.bioJohn.Doe@galatea.bio
47%
First@galatea.bioJohn@galatea.bio
3%

Frequently Asked Questions

Where is Galatea Bio Inc.'s headquarters located?

Minus sign iconPlus sign icon
Galatea Bio Inc.'s main headquarters is located at 14350 Commerce Way, Miami Lakes, Florida 33016, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Galatea Bio Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Galatea Bio Inc.'s official website is galatea.bio and has social profiles on LinkedInCrunchbase.

What is Galatea Bio Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Galatea Bio Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Galatea Bio Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Galatea Bio Inc. has approximately 34 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. D.Chief Medical Officer And Svp Biopharma And Healthcare Partnerships: J. G.Chief Of Staff: R. B.. Explore Galatea Bio Inc.'s employee directory with LeadIQ.

What industry does Galatea Bio Inc. belong to?

Minus sign iconPlus sign icon
Galatea Bio Inc. operates in the Biotechnology Research industry.

What technology does Galatea Bio Inc. use?

Minus sign iconPlus sign icon
Galatea Bio Inc.'s tech stack includes Cloudflare Web OptimizationsAmazon Simple Email ServiceGoogle Fonts APIReact RouterjQueryHSTSYouTubeHTTP/3.

What is Galatea Bio Inc.'s email format?

Minus sign iconPlus sign icon
Galatea Bio Inc.'s email format typically follows the pattern of First.Last@galatea.bio. Find more Galatea Bio Inc. email formats with LeadIQ.

How much funding has Galatea Bio Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Galatea Bio Inc. has raised $8M in funding. The last funding round occurred on Mar 27, 2025 for $8M.

When was Galatea Bio Inc. founded?

Minus sign iconPlus sign icon
Galatea Bio Inc. was founded in 2020.

Galatea Bio Inc.

Biotechnology ResearchUnited States11-50 Employees

We are building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and  accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups. 

Core to our mission is building trust with the communities we serve and long term partnerships with communities, researchers, clinicians, and most of all patients and their families.

This is your biobank and for the benefit of all. If we build it, we can decide how the data are used. And no one is going to do it for us, so let’s roll up our sleeves and “time to build.” Join us!

Este biobanco es tuyo y para todo el continente porque si lo construimos juntos podemos decidir cómo se usan los datos y con que fines. Nadie lo va a hacer por nosotros así que bienvenido a nuestro esfuerzo. Unete!

Section iconCompany Overview

Headquarters
14350 Commerce Way, Miami Lakes, Florida 33016, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $8M

    Galatea Bio Inc. has raised a total of $8M of funding over 4 rounds. Their latest funding round was raised on Mar 27, 2025 in the amount of $8M.

  • $10M$25M

    Galatea Bio Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $8M

    Galatea Bio Inc. has raised a total of $8M of funding over 4 rounds. Their latest funding round was raised on Mar 27, 2025 in the amount of $8M.

  • $10M$25M

    Galatea Bio Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.